⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Charcoal, Activated SCHEMBL57946 | 1.00 | — | — | |
| Charcoal, Activated SCHEMBL2250450 | 1.00 | — | — | |
| Charcoal, Activated SCHEMBL891528 | 0.82 | — | — | |
| Charcoal, Activated SCHEMBL7749008 | 0.82 | — | — | |
| Charcoal, Activated SCHEMBL9023682 | 0.82 | — | — | |
| Charcoal, Activated SCHEMBL11413838 | 0.82 | — | — | |
| Charcoal, Activated SCHEMBL370563 | 0.82 | — | — | |
| Charcoal, Activated SCHEMBL10888413 | 0.82 | — | — | |
| Charcoal, Activated SCHEMBL3139211 | 0.82 | — | — | |
| Charcoal, Activated SCHEMBL1078466 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209520-A1 | APPARATUS FOR MANUFACTURING NITROGEN-CONTAINING COMPOUND AND METHOD FOR MANUFACTURING NITROGEN-CONTAINING COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-06-27 | — | — | US | disclosed |
| EP-4332270-A1 | APPARATUS FOR MANUFACTURING NITROGEN-CONTAINING COMPOUND AND METHOD FOR MANUFACTURING NITROGEN-CONTAINING COMPOUND | Idemitsu Kosan Co., Ltd (JP) | 2024-03-06 | — | — | EP | disclosed |
| CN-117242206-A | Nitrogen-containing compound production apparatus and nitrogen-containing compound production method | 出光兴产株式会社 | 2023-12-15 | — | — | CN | disclosed |
| EP-3384900-B1 | STABLE DOSAGE FORM OF ETIDRONATE-CYTARABINE CONJUGATE | MAXWELL BIOTECH GROUP LTD (RU) | 2023-08-09 | — | — | EP | disclosed |
| WO-2023033185-A1 | METHOD FOR PRODUCING AMMONIA, MOLYBDENUM COMPLEX USED IN SAID PRODUCTION METHOD, AND LIGAND THAT IS STARTING MATERIAL FOR SAID MOLYBDENUM COMPLEX | 国立大学法人東京大学 | 2023-03-09 | — | — | WO | disclosed |
| WO-2022230896-A1 | APPARATUS FOR MANUFACTURING NITROGEN-CONTAINING COMPOUND AND METHOD FOR MANUFACTURING NITROGEN-CONTAINING COMPOUND | 出光興産株式会社 | 2022-11-03 | — | — | WO | disclosed |
| US-11219603-B2 | Stable dosage form of etidronate-cytarabine conjugate, and use thereof | MAXWELL BIOTECH GROUP LTD. (RU) | 2022-01-11 | — | — | US | disclosed |
| US-20210379108-A1 | CAR T-CELLS FOR THE TREATMENT OF BONE METASTATIC CANCER | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2021-12-09 | — | — | US | disclosed |
| US-11045487-B2 | Pharmaceutical preparation treating bone lesions caused by malignant neoplasms | MAXWELL BIOTECH GROUP LTD. (RU) | 2021-06-29 | — | — | US | disclosed |
| US-20210177903-A1 | CAR T-CELLS FOR THE TREATMENT OF BONE METASTATIC CANCER | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. | 2021-06-17 | — | — | US | disclosed |
| US-6572874-B1 | For treatment of osteoporosis and related bone and skeleton diseases; alendronate, clodronate, etidronate, pamidronate, tiludronate, ibandronate, neridronate, risedronate, zoledronate and olpadronate | UMD, INC. | 2003-06-03 | — | — | US | disclosed |
| EP-1311213-A1 | VAGINAL DELIVERY OF BISPHOSPHONATES | UMD, Inc. (US) | 2003-05-21 | — | — | EP | disclosed |
| EP-1131100-B1 | THERAPEUTIC COMPOSITIONS FOR METABOLIC BONE DISORDERS OR BONE METASTASES COMPRISING A PHOTOSENSITIZER AND A BISPHOSPHONATE | LIGHT SCIENCES CORP (US) | 2003-03-12 | — | — | EP | disclosed |
| US-20030018371-A1 | Compositions and methods for the treatment of metabolic bone disorders and bone metastases | LIGHT SCIENCES CORPORATION | 2003-01-23 | — | — | US | disclosed |
| US-20020142997-A1 | Liquid pharmaceutical composition for treating bone diseases | RIDERWAY CORPORATION | 2002-10-03 | — | — | US | disclosed |
| WO-2002070438-A2 | COMPOSITIONS FOR DELIVERING BISPHOSPHONATES | EMISPHERE TECHNOLOGIES, INC. (US) | 2002-09-12 | — | — | WO | disclosed |
| EP-1228761-A2 | Liquid pharmaceutical composition for treating bone diseases | Riderway Corporation (PA) | 2002-08-07 | — | — | EP | disclosed |
| WO-2002009631-A1 | VAGINAL DELIVERY OF BISPHOSPHONATES | UMD, INC. (US) | 2002-02-07 | — | — | WO | disclosed |
| EP-1131100-A2 | THERAPEUTIC COMPOSITIONS FOR METABOLIC BONE DISORDERS OR BONE METASTASES | Light Sciences Corporation (US) | 2001-09-12 | — | — | EP | disclosed |
| WO-2000041725-A2 | THERAPEUTIC COMPOSITIONS FOR METABOLIC BONE DISORDERS OR BONE METASTASES | LIGHT SCIENCES CORPORATION (US) | 2000-07-20 | — | — | WO | disclosed |